182 related articles for article (PubMed ID: 37632633)
1. Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia.
Guo Z; Guo D; Kong D; Bian S; Zhao L; Li Q; Lin L; Hao J; Sun L; Li Y
Mol Biol Rep; 2023 Oct; 50(10):8445-8457. PubMed ID: 37632633
[TBL] [Abstract][Full Text] [Related]
2. A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia.
Lin L; Wang Y; Bian S; Sun L; Guo Z; Kong D; Zhao L; Guo D; Li Q; Wu M; Wang Y; Wang Y; Li Y
J Transl Med; 2021 Mar; 19(1):123. PubMed ID: 33757550
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration.
Lv C; Sun L; Guo Z; Li H; Kong D; Xu B; Lin L; Liu T; Guo D; Zhou J; Li Y
J Transl Med; 2018 Dec; 16(1):361. PubMed ID: 30558617
[TBL] [Abstract][Full Text] [Related]
4. The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia.
Han C; He S; Wang R; Gao X; Wang H; Qiao J; Meng X; Li Y; Yu L
J Transl Med; 2021 Feb; 19(1):65. PubMed ID: 33579308
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.
Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY
BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia.
Dai Y; Cheng Z; Fricke DR; Zhao H; Huang W; Zhong Q; Zhu P; Zhang W; Wu Z; Lin Q; Zhu H; Liu Y; Qian T; Fu L; Cui L; Zeng T
J Cell Mol Med; 2021 Feb; 25(3):1456-1467. PubMed ID: 33417298
[TBL] [Abstract][Full Text] [Related]
7. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Zhao Y; Zhang T; Zhao Y; Zhou J
Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia.
Xu X; Sun R; Li Y; Wang J; Zhang M; Xiong X; Xie D; Jin X; Zhao M
BMC Med Genomics; 2023 May; 16(1):117. PubMed ID: 37237254
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis.
Yan H; Qu J; Cao W; Liu Y; Zheng G; Zhang E; Cai Z
Cancer Immunol Immunother; 2019 Dec; 68(12):1971-1978. PubMed ID: 31650199
[TBL] [Abstract][Full Text] [Related]
14. Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
Huang R; Liao X; Li J; Wei J; Su X; Lai X; Liu B; Zhu F; Huang Y; Li Q
Oncol Rep; 2019 May; 41(5):2876-2888. PubMed ID: 30896832
[TBL] [Abstract][Full Text] [Related]
15. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
16. Identification of mast cells as a candidate significant target of immunotherapy for acute myeloid leukemia.
Jia M; Zhang H; Wang L; Zhao L; Fan S; Xi Y
Hematology; 2021 Dec; 26(1):284-294. PubMed ID: 33648435
[TBL] [Abstract][Full Text] [Related]
17. Identification of six hub genes and analysis of their correlation with drug sensitivity in acute myeloid leukemia through bioinformatics.
Cai D; Liang J; Cai XD; Yang Y; Liu G; Zhou F; He D
Transl Cancer Res; 2021 Jan; 10(1):126-140. PubMed ID: 35116245
[TBL] [Abstract][Full Text] [Related]
18. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
Lai Y; Sheng L; Wang J; Zhou M; OuYang G
Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia.
Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Quan L; Qian T; Zeng T; Si C; Huang W; Chen J; Pang Y; Ye X; Shi J; Fu L
J Cell Mol Med; 2020 Jan; 24(1):1067-1075. PubMed ID: 31755224
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognosis analysis of
Zhang T; Zhao Y; Zhao Y; Zhou J
Aging (Albany NY); 2020 Mar; 12(6):5031-5047. PubMed ID: 32209730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
